Macquarie Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $24.9M | Buy |
|
|||||
|
2023
Q4 | $48.8M | Buy |
|
|||||
|
2023
Q3 | $35.5M | Buy |
|
|||||
|
2023
Q2 | $54.2M | Buy |
|
|||||
|
2023
Q1 | $46.5M | Buy |
|
|||||
|
2022
Q4 | $32.8M | Sell |
|
|||||
|
2022
Q3 | $23.4M | Buy |
|
|||||
|
2022
Q2 | $17.6M | Buy |
|
|||||
|
2022
Q1 | $35K | Buy |
|
|||||
|
2021
Q4 | $38.9M | Buy |
|
|||||
|
2021
Q3 | $5.3M | Sell |
|
|||||
|
2021
Q2 | $7.38M | Buy |
|
|||||
|
2021
Q1 | $6.34M | Sell |
|
|||||
|
2020
Q4 | $28M | Buy |
|
|||||
|
2020
Q3 | $19K | Hold |
|
|||||
|
2020
Q2 | $6K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $2.84M | Sell |
|
|||||
|
2016
Q2 | $4.46M | Buy |
|